News
Entertainment
Science & Technology
Sport
Business & Money
Life
Culture & Art
Hobbies
6 | Follower
Hospital Healthcare Europe
26.04.2024
The cystic fibrosis medication ivacaftor is safe and effective in infants from four weeks of age, a phase 3 trial has found.
Tislelizumab has been approved by the European Commission for use in patients with treatment-naive and relapsed non-small cell lung cancer.
27.04.2024
Specific nasal cells found in children protect against Covid-19 and may explain why younger people typically experience milder symptoms.
A biomarker-based strategy is comparable to an MRI-enhanced approach for prostate cancer screening, a randomised trial has found.